Overview
Hibiki Udagawa practices practicing medicine in Kashiwa, Japan.
Udagawa is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
They are actively involved in clinical research, co-authoring 63 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hibiki Udagawa
Is Hibiki Udagawa a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Hibiki Udagawa is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hibiki Udagawa participate in research or clinical trials?
Yes. Hibiki Udagawa has published 63 articles and abstracts on conditions like Lung Cancer. You can view a list of Hibiki Udagawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerUdagawa isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung CancerUdagawa isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Udagawa isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Udagawa isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Acute Interstitial PneumoniaUdagawa isExperienced. Learn about Acute Interstitial Pneumonia.
- Adenoid Cystic CarcinomaUdagawa isExperienced. Learn about Adenoid Cystic Carcinoma.
- AgranulocytosisUdagawa isExperienced. Learn about Agranulocytosis.
- Esophageal CancerUdagawa isExperienced. Learn about Esophageal Cancer.
- Febrile NeutropeniaUdagawa isExperienced. Learn about Febrile Neutropenia.
- Interstitial Lung DiseaseUdagawa isExperienced. Learn about Interstitial Lung Disease.
- Lung AdenocarcinomaUdagawa isExperienced. Learn about Lung Adenocarcinoma.
- Lung MetastasesUdagawa isExperienced. Learn about Lung Metastases.
- Lymphofollicular HyperplasiaUdagawa isExperienced. Learn about Lymphofollicular Hyperplasia.
- Neuroendocrine TumorUdagawa isExperienced. Learn about Neuroendocrine Tumor.
- Pleural EffusionUdagawa isExperienced. Learn about Pleural Effusion.
- PneumoniaUdagawa isExperienced. Learn about Pneumonia.
- RetinoblastomaUdagawa isExperienced. Learn about Retinoblastoma.
- Squamous Cell Lung CarcinomaUdagawa isExperienced. Learn about Squamous Cell Lung Carcinoma.